Fluorescent-guided robotic lung surgery for early lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Your lung tumor must be smaller than 3 centimeters
- You must have stage 1 non-small cell lung cancer
- Your CT scan must show the tumor is limited to one lung segment (so segment removal is appropriate)
- You must not be allergic to the study dye or related iodine-based substances (ICG, sodium iodide/iodine)
- If you can get pregnant, you must use reliable birth control; pregnancy or breastfeeding is not allowed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This trial tests a new method using 3D virtual reality and a special dye (indocyanine green) to help surgeons see and remove only the affected part of the lung, preserving healthy tissue. It is for people with early-stage lung cancer that is small and located in one section of the lung.
This trial tests whether using special near-infrared imaging can help surgeons better guide lung tumor removal during minimally invasive or open chest surgery. It may improve how accurately the surgical area is identified during the operation.
This trial compares two methods to help surgeons find the right section of the lung to remove during surgery. One method uses a special green dye, and the other uses air to inflate and deflate the lung. The goal is to find which is better at helping the surgeon remove only the sick part while saving healthy tissue.
This trial studies a dye-based technique (using indocyanine green) to help surgeons identify lung segments during a lung cancer operation (segmentectomy). The goal is to improve how accurately and safely surgeons remove the affected part of the lung.
This trial studies whether a fluorescent dye (a “tracer”) can help surgeons find the right area during laparoscopic distal (lower-part) stomach removal for early stomach cancer. It may improve how completely the cancer is removed while keeping surgery minimally invasive.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.